Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization

SARS-CoV-2 infection is the cause of the disease named COVID-19, a major public health challenge worldwide. Differences in the severity, complications and outcomes of the COVID-19 are intriguing and, patients with similar baseline clinical conditions may have very different evolution. Myeloid-derive...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez-Cortegana, Carlos, Salamanca, Elena, Palazón-Carrión, Natalia, Sánchez-Jiménez, Flora, Pérez-Pérez, Antonio, Vilariño-García, Teresa, Fuentes, Sandra, Martín, Salomón, Jiménez, Marta, Galván, Raquel, Rodríguez-Chacón, Carmen, Sánchez-Mora, Catalina, Moreno-Mellado, Elisa, Gutiérrez-Gutiérrez, Belén, Álvarez, Nerissa, Sosa, Alberto, Garnacho-Montero, José, de la Cruz-Merino, Luis, Rodríguez-Baño, Jesús, Sánchez-Margalet, Víctor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685891/
https://www.ncbi.nlm.nih.gov/pubmed/38035104
http://dx.doi.org/10.3389/fimmu.2023.1266659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685891/
https://www.ncbi.nlm.nih.gov/pubmed/38035104
http://dx.doi.org/10.3389/fimmu.2023.1266659

Ejemplares similares